Large gap with delayed quotes
|
Last quote
12/27/2024 -
20:00:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
16.83
-0.45
(
-2.60% )
|
16.81
|
1,100 |
16.83
|
2,100 |
Analysis date: 24.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 20.12.2024.
Interest
Strong
Strong
Strong interest since 05.11.2024.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 01.10.2024 at a price of 13.81.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
Positive
Positive
The forty day Medium Term Technical Trend is positive since 05.11.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 16.151.
4wk Rel Perf
0.42%
0.42%
The four week relative performance versus SP500 is .
Sensibility
High
High
The stock has been on the high-sensitivity level since 20.12.2024.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 0.88%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.69%.
Mkt Cap in $bn
2.12
2.12
With a market capitalization between $2 & $8bn, NEOGENOMICS is considered a mid-cap stock.
G/PE Ratio
1.41
1.41
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
52.80
52.80
The estimated PE is for the year 2026.
LT Growth
74.50%
74.50%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
13
13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
159
159
For 1% of index variation, the stock varies on average by 1.59%.
Correlation
0.41
0.41
40.85% of stock movements are explained by index variations.
Value at Risk
7.53
7.53
The value at risk is estimated at USD 7.53. The risk is therefore 43.91%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.11.2020
27.11.2020